NCT00261170View on ClinicalTrials.gov

Bupropion for Hospital-Based Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2006

Study Completion Date

February 28, 2007

Conditions
Smoking
Interventions
DRUG

bupropion

150 mg daily for the first 3 days, then 150 mg twice daily for 7 weeks

OTHER

placebo

1 pill daily for the first 3 days, then one pill twice daily for 7 weeks

Trial Locations (1)

94121

Veterans Affairs Medical Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00261170 - Bupropion for Hospital-Based Smoking Cessation | Biotech Hunter | Biotech Hunter